Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

AstraZeneca’s AZD0780 is an investigational oral medication that was developed to lower low-density lipoprotein cholesterol ...

Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

The latest news from ACC.25 including abstracts, features, and helpful conference information. A digital monitoring program reduced readmission rates and bolstered cardiac rehabilitation enrollment ...

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), ...

We recently published a list of Top 9 AI Ratings and News Updates on Wall Street’s Radar. In this article, we are going to ...

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral ...

trustee of the American College of Cardiology (ACC) and cardiologist at North Shore University Hospital and Long Island Jewish Medical Center in New York. Here at the annual meeting of the ACC ...